Metastatic cutaneous Crohn’s disease of the face
| Autor: | Susana Rodrigues, Fernando Magro, Guilherme Macedo, Fátima Carneiro, José Macedo Dias, Susana M. Chuva de Sousa Lopes, Andreia Albuquerque, Joanne Lopes |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Adult
Male medicine.medical_specialty Triamcinolone acetonide Adolescent Biopsy Azathioprine Young Adult chemistry.chemical_compound Crohn Disease Mesalazine Sulfasalazine Prednisone Erythematous plaque medicine Humans Forehead Skin Crohn's disease Granuloma Hepatology business.industry Gastroenterology Middle Aged medicine.disease Dermatology Infliximab chemistry Female business Facial Dermatoses medicine.drug |
| Zdroj: | European Journal of Gastroenterology & Hepatology. 23:954-956 |
| ISSN: | 0954-691X |
| DOI: | 10.1097/meg.0b013e328348d706 |
| Popis: | Summary of the features of metastatic cutaneous Crohn’s disease of the face based on eight case reports available in the published literature SexAge(years)MontrealclassificationActivity orremissionTreatment of CDbefore MCDTemporal relationshipbetween MCD and CDYears of CDevolutionLocation ofMCD on the faceTreatmentof MCD Type of lesionCasereferencesMale 31 A2L2NDp Activity Azathioprine andmethylprednisoloneAfter diagnosisof CD9 Temporal+submandibularOral mesalazine, oralmethylprednisolone, andsulfasalazine 3% oimenton the skinPlaques [1]Female 45 ND ND Infliximab ND ND Malar+supraorbitary ND Erythematous plaques [2]Male 16 A1L3ND Remission? Prednisone, 6-MPand olsalazineAfter diagnosis of CD 3 Chin+malar+perioral Prednisone and dapsone Papulonodular [3]Female 63 A2L2B3 Remission Infliximab After diagnosis of CD 30 Chin+malar+perioral Infliximab, ciprofloxacin, andtopical steroidsErythema+ulceration [4]Female 35 A2L3B3 Remission Totalproctocolectomywith ileostomyNo medicationAfter diagnosis of CD 5 Forehead None Erythematous [7]Female 44 A2L3ND Remission? ND After diagnosis of CD 17 Malar Topical flucinolone acetonide0.01% creamErysipela-like plaque [8]Female 44 A2L3B2 Activity ND After diagnosis of CD 22 Perioral region Oral sulfasalazine Erythematous plaques [9]Male 36 A2L2 NDp Activity Sulfasalazine After diagnosis of CD 14 Chin Intralesional triamcinolone Erythematous nodulesand plaques[10]CD, Crohn’s disease; MCD, metastatic Crohn’s disease; ND, not described. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|